About the Company
We do not have any company description for Absci Corp at the moment.
Sector
Industrial Applications and Services
Industry
Services-Commercial Physical & Biological Research
Employees
193
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ABSI News
Absci Corporation (ABSI)
VANCOUVER, Wash. and NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report ...
Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May ...
Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates ...
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
and NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today reported financial and operating results for the fourth ...
Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?
Absci Corporation (ABSI) shares rallied 16.8% in the last trading session to close at $6.59. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
Absci (NASDAQ: ABSI)
Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech ...
Absci Corporation (ABSI) Surges 10.0%: Is This an Indication of Further Gains?
Absci Corporation (ABSI) shares rallied 10% in the last trading session to close at $5.16. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
Buy Rating Affirmed for AbSci: Promising Pipeline and Strategic Partnerships Signal Growth
Begin your TipRanks Premium journey today. AbSci (ABSI) Company Description: Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the ...
Absci Corp.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Absci Announces Proposed Public Offering of Common Stock
Absci Corporation (Nasdaq: ABSI) (“Absci”), a data-first generative AI drug creation company, announced today that it has commenced an underwritten public offering of $75.0 million of shares ...
Loading the latest forecasts...